¿Es origanum majorana leaf extract seguro durante el embarazo?
No harmonised CLP reproductive classifications for Origanum majorana leaf extract and no SCCS/CIR safety assessment identifying reproductive risks. PubMed literature does not show human teratogenic or reproductive toxicity data for the extract; botanical constituents (terpenes, phenolics) do not individually trigger harmonised reproductive flags. Dermal absorption from topical use is expected to be low but measurable, so exposure is scored as low (evidence: CosIng/ECHA entries list the extract without restrictions; PubChem lists constituent volatiles but no reproductive alerts).
Pregnancy-safe products containing origanum majorana leaf extract










Related ingredients
Frequently asked questions
- ¿Es origanum majorana leaf extract seguro durante el embarazo?
- No harmonised CLP reproductive classifications for Origanum majorana leaf extract and no SCCS/CIR safety assessment identifying reproductive risks. PubMed literature does not show human teratogenic or reproductive toxicity data for the extract; botanical constituents (terpenes, phenolics) do not individually trigger harmonised reproductive flags. Dermal absorption from topical use is expected to be low but measurable, so exposure is scored as low (evidence: CosIng/ECHA entries list the extract without restrictions; PubChem lists constituent volatiles but no reproductive alerts).
- ¿Es origanum majorana leaf extract seguro durante la lactancia?
- No evidence of reproductive or lactation-specific toxicity in authoritative sources. No harmonised classification or SCCS/CIR concern. Potential for low dermal absorption exists, but no data showing transfer into breastmilk; exposure scored as low (CosIng/ECHA/PubChem; absence of CIR/SCCS warnings).
- ¿Es origanum majorana leaf extract seguro para la piel del bebé?
- No infant-specific safety signals or harmonised reproductive classifications. However, because infant skin has higher permeability and surface-area-to-weight ratio, exposure scoring is increased by +1 (adult e=1 → infant e=2). No data support increased hazard or a specific reproductive mechanism in infants.
- ¿Cómo puntúa VeriMom a origanum majorana leaf extract?
- VeriMom puntúa origanum majorana leaf extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a origanum majorana leaf extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a origanum majorana leaf extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.